Larvol Delta - Marker-Therapeutics-Announces-First-Lymphoma-Patient-Treated-with-MT601-in-Phase-1-Clinical-Trial

MT-601 - Marker Therap

https://www.globenewswire.com/news-release/2023/06/12/2686164/0/en/Marker-Therapeutics-Announces-First-Lymphoma-Patient-Treated-with-MT-601-in-Phase-1-Clinical-Trial.html

Jun 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next